1-20 of 20
W.E. Berdel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Clinical and Pharmacokinetic Study of LU103793 (Cemadotin Hydrochloride) as an Intravenous Bolus Injection in Patients with Metastatic Solid Tumors: A Study of the AIO Phase I and APOH Group of the German Cancer Society

Available to Purchase
Subject Area:
Oncology
K. Mross, K. Herbst, W.E. Berdel, A. Korfel, I.-M. von Broen, Y. Bankmann, D.K. Hossfeld
Journal: Onkologie
Onkologie (1996) 19 (6): 490–495.
https://doi.org/10.1159/000218861
Published Online: 12 May 2009
View articletitled, Phase I Clinical and Pharmacokinetic Study of LU103793 (Cemadotin Hydrochloride) as an Intravenous Bolus Injection in Patients with Metastatic Solid Tumors: A Study of the AIO Phase I and APOH Group of the German Cancer Society
Open the PDF for Phase I Clinical and Pharmacokinetic Study of LU103793 (Cemadotin Hydrochloride) as an Intravenous Bolus Injection in Patients with Metastatic Solid Tumors: A Study of the AIO Phase I and APOH Group of the German Cancer Society in another window
Journal Articles

Standard-Arbeitsanweisungen (Standard Operating Procedures, SOP) der Phase l/ll-Studiengruppe der Arbeitsgemeinschaft für Internistische Onkologie (AIO) in der Deutschen Krebsgesellschaft

Available to Purchase
Subject Area:
Oncology
W.E. Berdel, R. Becher, L. Edler, A.-R. Hanauske, S. Kerpel-Fronius, W. Rauschning, H.-J. Schmoll, H. Sindermann
Journal: Onkologie
Onkologie (1994) 17 (3): 311–338.
https://doi.org/10.1159/000218434
Published Online: 11 May 2009
View articletitled, Standard-Arbeitsanweisungen (Standard Operating Procedures, SOP) der Phase l/ll-Studiengruppe der Arbeitsgemeinschaft für Internistische Onkologie (AIO) in der Deutschen Krebsgesellschaft
Open the PDF for Standard-Arbeitsanweisungen (Standard Operating Procedures, SOP) der Phase l/ll-Studiengruppe der Arbeitsgemeinschaft für Internistische Onkologie (AIO) in der Deutschen Krebsgesellschaft in another window
Journal Articles

Influence of Recombinant Human lnterleukin-10 (IL-10) on the Clonal Growth of Human Malignant Lymphoid Cell Lines and Cell Lines from Human Solid Tumors in vitro

Available to Purchase
Subject Area:
Oncology
W.E. Berdel, E. Oelmann, C.A. Papadimitriou, M. Koenigsmann, B. Reufi, D. Oberberg, E. Thiel
Journal: Onkologie
Onkologie (1994) 17 (3): 280–283.
https://doi.org/10.1159/000218426
Published Online: 11 May 2009
View articletitled, Influence of Recombinant Human lnterleukin-10 (IL-10) on the Clonal Growth of Human Malignant Lymphoid Cell Lines and Cell Lines from Human Solid Tumors in vitro
Open the PDF for Influence of Recombinant Human lnterleukin-10 (IL-10) on the Clonal Growth of Human Malignant Lymphoid Cell Lines and Cell Lines from Human Solid Tumors in vitro in another window
Journal Articles

Quantifying Cell Adhesion of the Colon Cancer Cell Line HT 29 to Extracellular Matrix Proteins: Comparative Evaluation of an Isotopic, a Fluorometric, and a Colorimetric Method

Available to Purchase
Subject Area:
Oncology
M. Koenigsmann, M. Streit, E.D. Kreuser, U. Harms, J. Schulz, U. Mansmann, E. Thiel, W.E. Berdel
Journal: Onkologie
Onkologie (1994) 17 (5): 528–537.
https://doi.org/10.1159/000218469
Published Online: 11 May 2009
View articletitled, Quantifying Cell Adhesion of the Colon Cancer Cell Line HT 29 to Extracellular Matrix Proteins: Comparative Evaluation of an Isotopic, a Fluorometric, and a Colorimetric Method
Open the PDF for Quantifying Cell Adhesion of the Colon Cancer Cell Line HT 29 to Extracellular Matrix Proteins: Comparative Evaluation of an Isotopic, a Fluorometric, and a Colorimetric Method in another window
Journal Articles

Tenth Anniversary of the Phase-ll Study Group in the Association for Medical Oncology (AIO) of the German Cancer Society

Free
Subject Area:
Oncology
W. Queißer, H.H. Fiebig, W.E. Berdel
Journal: Onkologie
Onkologie (1994) 17 (3): 210.
https://doi.org/10.1159/000218415
Published Online: 11 May 2009
View articletitled, Tenth Anniversary of the Phase-ll Study Group in the Association for Medical Oncology (AIO) of the German Cancer Society
Open the PDF for Tenth Anniversary of the Phase-ll Study Group in the Association for Medical Oncology (AIO) of the German Cancer Society in another window
Journal Articles

A Venous Access Mini-Port Implanted on the Proximal Forearm, on the Distal Upper Arm or on the Chest Wall

Available to Purchase
Subject Area:
Oncology
W.E. Berdel, K. Ridwelski, A. Korfel, M. Matthias, B.-M. Harnoss, J. Boese-Landgraf, E. May, E. Thiel
Journal: Onkologie
Onkologie (1993) 16 (6): 454–460.
https://doi.org/10.1159/000218306
Published Online: 08 May 2009
View articletitled, A Venous Access Mini-Port Implanted on the Proximal Forearm, on the Distal Upper Arm or on the Chest Wall
Open the PDF for A Venous Access Mini-Port Implanted on the Proximal Forearm, on the Distal Upper Arm or on the Chest Wall in another window
Journal Articles

Topically Applied Miltefosine (Hexadecylphosphocholine) in Patients with Skin-Metastasized Breast Cancer. A Phase II Study

Available to Purchase
Subject Area:
Oncology
C. linger, R. Herrmann, W.E. Berdel, U.R. Kleeberg, U. Gatzemeier, H.J. Illiger, H.E. Wander, M. Westerhausen, R. Becher, K. Bremer, K. Rieche, U. Essers, W. Queißer, E. Heidemann, H.H. Fiebig, K. Possinger, B. Jourdain-Madl, M.E. Heim, L. Edler
Journal: Onkologie
Onkologie (1993) 16 (3): 170–173.
https://doi.org/10.1159/000218252
Published Online: 08 May 2009
View articletitled, Topically Applied Miltefosine (Hexadecylphosphocholine) in Patients with Skin-Metastasized Breast Cancer. A Phase II Study
Open the PDF for Topically Applied Miltefosine (Hexadecylphosphocholine) in Patients with Skin-Metastasized Breast Cancer. A Phase II Study in another window
Journal Articles

A Multicenter Prospective Randomized Trial with Assessment of Quality of Life in Patients with Metastatic Colorectal Carcinoma Comparing Interferon α-2b and Folinic Acid as Modulators of 5-Fluorouracil

Available to Purchase
Subject Area:
Oncology
E.D. Kreuser, T. Küchler, T. Zwingers, M. Matthias, K. Ridwelski, P.M. Ehrich, Ch. Boewer, D. Zillig, S.K. Jakob, P. David, M. Kairies, L. Reichel, R. Pasold, J. Reichert, W. Stein, R. Böthig, H.W. Dreyer°, W. Abenhardt, F. Bach, R.U. Hilgenfeld, S. Schwartz, J.B. Boese-L·andgraf, W.E. Berdel, E. Thiel
Journal: Onkologie
Onkologie (1994) 17 (1): 78–84.
https://doi.org/10.1159/000218387
Published Online: 08 May 2009
View articletitled, A Multicenter Prospective Randomized Trial with Assessment of Quality of Life in Patients with Metastatic Colorectal Carcinoma Comparing Interferon α-2b and Folinic Acid as Modulators of 5-Fluorouracil
Open the PDF for A Multicenter Prospective Randomized Trial with Assessment of Quality of Life in Patients with Metastatic Colorectal Carcinoma Comparing Interferon α-2b and Folinic Acid as Modulators of 5-Fluorouracil in another window
Journal Articles

Daily Oral Miltefosine (Hexadecyl-Phosphocholine) in Patients with Advanced Non-Small Cell Lung Cancer. A Phase II Study

Available to Purchase
Subject Area:
Oncology
W.E. Berdel, R. Becher, L. Edler, K. Bremer, U. Essers, A. Drozd, M. Zafferani, M.A.G. Klee, P. Bachmann, A. Korfel, M. Westerhausen
Journal: Onkologie
Onkologie (1992) 15 (3): 238–242.
https://doi.org/10.1159/000217364
Published Online: 29 April 2009
View articletitled, Daily Oral Miltefosine (Hexadecyl-Phosphocholine) in Patients with Advanced Non-Small Cell Lung Cancer. A Phase II Study
Open the PDF for Daily Oral Miltefosine (Hexadecyl-Phosphocholine) in Patients with Advanced Non-Small Cell Lung Cancer. A Phase II Study in another window
Journal Articles

Tumor Necrosis Factor in Advanced Colorectal Cancer: A Phase II Study: A Trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer Society

Available to Purchase
Subject Area:
Oncology
M.E. Heim, R. Siegmund, H.J. Illiger, M. Klee, K. Rieche, W.E. Berdel, L. Edler
Journal: Onkologie
Onkologie (1990) 13 (6): 444–447.
https://doi.org/10.1159/000216817
Published Online: 28 April 2009
View articletitled, Tumor Necrosis Factor in Advanced Colorectal Cancer: A Phase II Study: A Trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer Society
Open the PDF for Tumor Necrosis Factor in Advanced Colorectal Cancer: A Phase II Study: A Trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer Society in another window
Journal Articles

Stimulation of Clonal Growth of Human Colorectal Tumor Cells by IL-3 and GM-CSF: Modulation of 5-FU Cytotoxicity by GM-CSF

Available to Purchase
Subject Area:
Oncology
W.E. Berdel, S. Danhauser-Riedl, G. Steinhauser, J. Rastetter
Journal: Onkologie
Onkologie (1990) 13 (6): 437–443.
https://doi.org/10.1159/000216816
Published Online: 28 April 2009
View articletitled, Stimulation of Clonal Growth of Human Colorectal Tumor Cells by IL-3 and GM-CSF: Modulation of 5-FU Cytotoxicity by GM-CSF
Open the PDF for Stimulation of Clonal Growth of Human Colorectal Tumor Cells by IL-3 and GM-CSF: Modulation of 5-FU Cytotoxicity by GM-CSF in another window
Journal Articles

Ether Lipids and Derivatives as Investigational Anticancer Drugs: A Brief Review

Available to Purchase
Subject Area:
Oncology
W.E. Berdel
Journal: Onkologie
Onkologie (1990) 13 (4): 245–250.
https://doi.org/10.1159/000216771
Published Online: 28 April 2009
View articletitled, Ether Lipids and Derivatives as Investigational Anticancer Drugs: A Brief Review
Open the PDF for Ether Lipids and Derivatives as Investigational Anticancer Drugs: A Brief Review in another window
Journal Articles

Ondansetron (GR 38032F), ein kompetitiver 5-HT 3 -Rezeptor-Antagonist als Antiemetikum bei Zytostatika-induzierter übelkeit und Erbrechen: Eine offene, substanzorientierte Phase-II/III-Studie

Available to Purchase
Subject Area:
Oncology
H. Serve, M. Perker, A. Ertl, M. Reichold, U. Fink, W.E. Berdel
Journal: Onkologie
Onkologie (1990) 13 (5): 369–374.
https://doi.org/10.1159/000216798
Published Online: 28 April 2009
View articletitled, Ondansetron (GR 38032F), ein kompetitiver 5-HT 3 -Rezeptor-Antagonist als Antiemetikum bei Zytostatika-induzierter übelkeit und Erbrechen: Eine offene, substanzorientierte Phase-II/III-Studie
Open the PDF for Ondansetron (GR 38032F), ein kompetitiver 5-HT 3 -Rezeptor-Antagonist als Antiemetikum bei Zytostatika-induzierter übelkeit und Erbrechen: Eine offene, substanzorientierte Phase-II/III-Studie in another window
Journal Articles

Multizentrische prospektive kontrollierte Studie zur Therapie der chronisch myeloischen Leukämie. Vergleich von Busulfan, Hydroxyurea und Interferon alpha (Stand April 1990)

Available to Purchase
Subject Area:
Oncology
R. Hehlmann, H. Heimpel, B. Heinze, A. Georgii, H.J. Kolb, D.K. Hossfeld, P.v. Wussow, A. Hochhaus, M. Grießhammer, V. Diehl, P.D. Wickramanayake, W. Gallmeier, C. Falge, U. Essers, L. Bergmann, P. Meyer, F. Walther, L. Kanz, U. Queißer, J. Hohnloser, M. Westerhausen, U.R. Kleeberg, A. Heilein, A. Käbisch, F. Heiss, R. Zimmermann, G. Meuret, A. Tichelli, W.E. Berdel, N. Schmitz, F.-J. Tigges, H. Eimermacher, L. Schmid, H. Löffler, H. Pralle, W. Queißer, R. Burkhardt, H. Ansari, J. Hasford
Journal: Onkologie
Onkologie (1991) 14 (1): 66–73.
https://doi.org/10.1159/000216948
Published Online: 28 April 2009
View articletitled, Multizentrische prospektive kontrollierte Studie zur Therapie der chronisch myeloischen Leukämie. Vergleich von Busulfan, Hydroxyurea und Interferon alpha (Stand April 1990)
Open the PDF for Multizentrische prospektive kontrollierte Studie zur Therapie der chronisch myeloischen Leukämie. Vergleich von Busulfan, Hydroxyurea und Interferon alpha (Stand April 1990) in another window
Journal Articles

Ergebnisse der Chemotherapie inoperabler nicht-kleinzelliger Bronchial-karzinome mit VP 16–213 (Etoposid) und Cis-Platin: Eine Phase-II-Studie

Available to Purchase
Subject Area:
Oncology
T. Klippstein, M. Graubner, W.E. Berdel, S. Mende, C. Gropp, V. Diehl, P.S. Mitrou
Journal: Onkologie
Onkologie (1983) 6 (6): 306–311.
https://doi.org/10.1159/000215253
Published Online: 21 April 2009
View articletitled, Ergebnisse der Chemotherapie inoperabler nicht-kleinzelliger Bronchial-karzinome mit VP 16–213 (Etoposid) und Cis-Platin: Eine Phase-II-Studie
Open the PDF for Ergebnisse der Chemotherapie inoperabler nicht-kleinzelliger Bronchial-karzinome mit VP 16–213 (Etoposid) und Cis-Platin: Eine Phase-II-Studie in another window
Journal Articles

Angiogenese bei hämatologischen Neoplasien

Available to Purchase
Subject Area:
Oncology
R.M. Mesters, T. Padró, M. Steins, R. Bieker, S. Retzlaff, T. Kessler, J. Kienast, W.E. Berdel
Journal: Onkologie
Onkologie (2001) 24 (Suppl. 5): 75–80.
https://doi.org/10.1159/000055192
Published Online: 17 November 2004
View articletitled, Angiogenese bei hämatologischen Neoplasien
Open the PDF for Angiogenese bei hämatologischen Neoplasien in another window
Journal Articles

Problemorientiertes Lernen – interdisziplinäre Tumormedizin (poL-iT): Ein integriertes Modell der Universität Münster

Available to Purchase
Subject Area:
Oncology
W.E. Berdel, M. Zühlsdorf, R.P. Nippert, B. Marschall, M.J. Wilhelm, F. Stümpel, H. Herbst, S. Kliesch, F. Ramsthaler, W. Domschke
Journal: Onkologie
Onkologie (2001) 24 (6): 587–594.
https://doi.org/10.1159/000055148
Published Online: 11 January 2002
View articletitled, Problemorientiertes Lernen – interdisziplinäre Tumormedizin (poL-iT): Ein integriertes Modell der Universität Münster
Open the PDF for Problemorientiertes Lernen – interdisziplinäre Tumormedizin (poL-iT): Ein integriertes Modell der Universität Münster in another window
Journal Articles

Phase I Clinical Trial of a Day-1, -3, -5 Every 3 WeeksPhase I Clinical Trial of Day-1, -3, -5 Every 3 Weeks Schedule with Titanocene Dichloride (MKT 5) in Patients with Advanced Cancer. (Phase I Study Group of the AIO of the German Cancer Society)

Available to Purchase
Subject Area:
Oncology
K. Mross, P. Robben-Bathe, L. Edler, J. Baumgart, W.E. Berdel, H. Fiebig, C. Unger
Journal: Onkologie
Onkologie (2000) 23 (6): 576–579.
https://doi.org/10.1159/000055009
Published Online: 15 January 2001
View articletitled, Phase I Clinical Trial of a Day-1, -3, -5 Every 3 WeeksPhase I Clinical Trial of Day-1, -3, -5 Every 3 Weeks Schedule with Titanocene Dichloride (MKT 5) in Patients with Advanced Cancer. (Phase I Study Group of the AIO of the German Cancer Society)
Open the PDF for Phase I Clinical Trial of a Day-1, -3, -5 Every 3 WeeksPhase I Clinical Trial of Day-1, -3, -5 Every 3 Weeks Schedule with Titanocene Dichloride (MKT 5) in Patients with Advanced Cancer. (Phase I Study Group of the AIO of the German Cancer Society) in another window
Journal Articles

Phase I/II Study of Paclitaxel and 5-Fluorouracil as Second-Line Therapy in Patients with Metastatic Breast Cancer

Available to Purchase
Subject Area:
Oncology
B. Gleissner, A. Hellmann, W.E. Berdel, L. Edler, M. Koldehoff, A. Rost, F. Opri, D. Fritze, S. Öhl
Journal: Onkologie
Onkologie (1998) 21 (4): 305–308.
https://doi.org/10.1159/000026846
Published Online: 09 September 1998
View articletitled, Phase I/II Study of Paclitaxel and 5-Fluorouracil as Second-Line Therapy in Patients with Metastatic Breast Cancer
Open the PDF for Phase I/II Study of Paclitaxel and 5-Fluorouracil as Second-Line Therapy in Patients with Metastatic Breast Cancer in another window
Journal Articles

Megakaryocyte Growth and Development Factor Does Not Stimulate Growth of Lymphomas and Solid Tumors in vitro

Available to Purchase
Subject Area:
Oncology
W.E. Berdel, M.S. Topp, E. Oelmann, B. Reufi, H. Serve
Journal: Onkologie
Onkologie (1998) 21 (3): 224–226.
https://doi.org/10.1159/000026819
Published Online: 20 July 1998
View articletitled, Megakaryocyte Growth and Development Factor Does Not Stimulate Growth of Lymphomas and Solid Tumors in vitro
Open the PDF for Megakaryocyte Growth and Development Factor Does Not Stimulate Growth of Lymphomas and Solid Tumors in vitro in another window